Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support
Clinical / Economic Analysis and the common ABC / VEN analysis are currently used to estimate the qualitative and quantitative indicators of drug supply. Materials and methods. We used the official information from the national portals www.grls.rosminzdrav.ru and http://zakupki.gov.ru, on the import...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2019-10-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/302 |
| _version_ | 1797878882741780480 |
|---|---|
| author | E. V. Eliseeva E. S. Maneeva R. K. Goncharova A. V. Kropotov |
| author_facet | E. V. Eliseeva E. S. Maneeva R. K. Goncharova A. V. Kropotov |
| author_sort | E. V. Eliseeva |
| collection | DOAJ |
| description | Clinical / Economic Analysis and the common ABC / VEN analysis are currently used to estimate the qualitative and quantitative indicators of drug supply. Materials and methods. We used the official information from the national portals www.grls.rosminzdrav.ru and http://zakupki.gov.ru, on the imported medicines and the manufacturing countries related to “The Program for Providing Essential Medicines to Certain Categories of Citizens in the Russian Federation” in two regions of the Far Eastern Federal District. Results. In Region 1, the highest level of domestically produced drugs (68.7%) was observed in 2014; in 2014-2015 it dropped significantly to 53.8% and 54.1%, respectively. In Region 2, the similar values were 69.6% in 2014, with a trend to decrease to 66.0% in 2015, and 62.4% in 2016. The highest replacement rates were recorded for the moderate and low consumption categories – «B» and «C», and also for essential and non-essential medicines – «E» and «N». Discussion. The import replacement in the subsidized medicine supply is a complex dynamic process. The authors suggest that the reduced replacement of the imported drugs can be explained by both objective (the actual absence of the respective Russia-made analogues) and subjective (irrational approaches to the procurement of medicines due to the lack of an appropriate algorithm). Therefore, further work is needed to rationalize and advance the priority of the domestic medicines for the subsidized segment of drug supply.Conclusion. The study shows that the situation with the import replacement in the subsidized segment is satisfactory. However, the reduced number of domestically-produced medicines found in this study, necessitates changes in the procurement policy regarding the medicines fully manufactured in Russia. The present article proposes criteria for the assessment of import replacement and recommends measures for improving the work in this direction. |
| first_indexed | 2024-04-10T02:40:05Z |
| format | Article |
| id | doaj.art-7784e4d0fca241f08b53297c833159a5 |
| institution | Directory Open Access Journal |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| last_indexed | 2024-04-10T02:40:05Z |
| publishDate | 2019-10-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj.art-7784e4d0fca241f08b53297c833159a52023-03-13T07:48:16ZrusIRBIS LLCФармакоэкономика2070-49092070-49332019-10-0112321022010.17749/2070-4909.2019.12.3.210-220271Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal supportE. V. Eliseeva0E. S. Maneeva1R. K. Goncharova2A. V. Kropotov3Federal State Budgetary Educational Institution of Higher Education «Pacific State Medical University» of the Ministry of Healthcare of the Russian FederationFederal State Budgetary Educational Institution of Higher Education «Pacific State Medical University» of the Ministry of Healthcare of the Russian FederationFederal State Budgetary Educational Institution of Higher Education «Pacific State Medical University» of the Ministry of Healthcare of the Russian FederationFederal State Budgetary Educational Institution of Higher Education «Pacific State Medical University» of the Ministry of Healthcare of the Russian FederationClinical / Economic Analysis and the common ABC / VEN analysis are currently used to estimate the qualitative and quantitative indicators of drug supply. Materials and methods. We used the official information from the national portals www.grls.rosminzdrav.ru and http://zakupki.gov.ru, on the imported medicines and the manufacturing countries related to “The Program for Providing Essential Medicines to Certain Categories of Citizens in the Russian Federation” in two regions of the Far Eastern Federal District. Results. In Region 1, the highest level of domestically produced drugs (68.7%) was observed in 2014; in 2014-2015 it dropped significantly to 53.8% and 54.1%, respectively. In Region 2, the similar values were 69.6% in 2014, with a trend to decrease to 66.0% in 2015, and 62.4% in 2016. The highest replacement rates were recorded for the moderate and low consumption categories – «B» and «C», and also for essential and non-essential medicines – «E» and «N». Discussion. The import replacement in the subsidized medicine supply is a complex dynamic process. The authors suggest that the reduced replacement of the imported drugs can be explained by both objective (the actual absence of the respective Russia-made analogues) and subjective (irrational approaches to the procurement of medicines due to the lack of an appropriate algorithm). Therefore, further work is needed to rationalize and advance the priority of the domestic medicines for the subsidized segment of drug supply.Conclusion. The study shows that the situation with the import replacement in the subsidized segment is satisfactory. However, the reduced number of domestically-produced medicines found in this study, necessitates changes in the procurement policy regarding the medicines fully manufactured in Russia. The present article proposes criteria for the assessment of import replacement and recommends measures for improving the work in this direction.https://www.pharmacoeconomics.ru/jour/article/view/302import replacementclinical and economic analysissubsidized drug supply |
| spellingShingle | E. V. Eliseeva E. S. Maneeva R. K. Goncharova A. V. Kropotov Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support Фармакоэкономика import replacement clinical and economic analysis subsidized drug supply |
| title | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support |
| title_full | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support |
| title_fullStr | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support |
| title_full_unstemmed | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support |
| title_short | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support |
| title_sort | clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support |
| topic | import replacement clinical and economic analysis subsidized drug supply |
| url | https://www.pharmacoeconomics.ru/jour/article/view/302 |
| work_keys_str_mv | AT eveliseeva clinicalandeconomicanalysisasaninstrumentforharmonizingimportsubstitutioninthepreferentialsegmentofmedicinalsupport AT esmaneeva clinicalandeconomicanalysisasaninstrumentforharmonizingimportsubstitutioninthepreferentialsegmentofmedicinalsupport AT rkgoncharova clinicalandeconomicanalysisasaninstrumentforharmonizingimportsubstitutioninthepreferentialsegmentofmedicinalsupport AT avkropotov clinicalandeconomicanalysisasaninstrumentforharmonizingimportsubstitutioninthepreferentialsegmentofmedicinalsupport |